| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.11 | 0.07 |